HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polymorphisms in the myosin light chain kinase gene that confer risk of severe sepsis are associated with a lower risk of asthma.

AbstractBACKGROUND:
Myosin light chain kinase (MYLK) is a multifunctional protein involved in regulation of airway hyperreactivity and other activities relevant to asthma.
OBJECTIVE:
To determine the role of MYLK gene variants in asthma among African Caribbean and African American populations.
METHODS:
We performed association tests between single nucleotide polymorphisms (SNPs) in the MYLK gene and asthma susceptibility and total serum IgE concentrations in 2 independent, family-based populations of African descent. Previously we identified variants/haplotypes in MYLK that confer risk for sepsis and acute lung injury; we compared findings from our asthma populations to findings in the African American sepsis and acute lung injury groups.
RESULTS:
Significant associations between MYLK SNPs and asthma and total serum IgE concentrations were observed in the African Caribbean families: a promoter SNP (rs936170) in the smooth muscle form gave the strongest association (P = .009). A haplotype including rs936170 corresponding to the actin-binding activity of the nonmuscle and smooth muscle forms was negatively associated with asthma (eg, decreased risk) in both the American (P = .005) and Caribbean families (P = .004), and was the same haplotype that conferred risk for severe sepsis (P = .002). RNA expression studies on PBMCs and rs936170 suggested a significant decrease in MYLK expression among patients with asthma with this variant (P = .025).
CONCLUSION:
MYLK polymorphisms may function as a common genetic factor in clinically distinct diseases involving bronchial smooth muscle contraction and inflammation.
CLINICAL IMPLICATIONS:
Genetic variants in MYLK are significantly associated with both asthma and sepsis in populations of African ancestry.
AuthorsLi Gao, Audrey V Grant, Nicholas Rafaels, Maria Stockton-Porter, Tonya Watkins, Peisong Gao, Peter Chi, Melba Muñoz, Harold Watson, Georgia Dunston, Alkis Togias, Nadia Hansel, Jonathan Sevransky, James P Maloney, Marc Moss, Carl Shanholtz, Roy Brower, Joe G N Garcia, Dmitry N Grigoryev, Christopher Cheadle, Terri H Beaty, Rasika A Mathias, Kathleen C Barnes
JournalThe Journal of allergy and clinical immunology (J Allergy Clin Immunol) Vol. 119 Issue 5 Pg. 1111-8 (May 2007) ISSN: 0091-6749 [Print] United States
PMID17472811 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Myosin-Light-Chain Kinase
Topics
  • Black or African American (genetics)
  • Asthma (genetics)
  • Black People (genetics)
  • Caribbean Region
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Myosin-Light-Chain Kinase (genetics)
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Sepsis (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: